Tuberculosis, also known as TB, is an illness that affects the lungs and is caused by a type of bacteria called Mycobacterium tuberculosis complex. TB can spread when a person with the illness coughs, ...
The US Food and Drug Administration (FDA) has approved QuantiFERON-TB Gold Plus (QFT-Plus); (QUIAGEN NV), a fourth generation latent tuberculosis (TB) blood test that combines CD4/CD8 ratio design to ...
Tuberculosis, or TB, is a disease that infects nearly 11 million people worldwide, killing some 1.25 million of them every year, per data from the World Health Organization. A person infected with the ...
HILDEN, Germany & GERMANTOWN, Md. & SHANGHAI--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QuantiFERON tuberculosis (TB) testing solution has ...
Qiagen ($QGEN) has started marketing a next-generation tuberculosis blood test in China, four months after winning regulatory approval there in what will be a key ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis ...
The Kerala health authorities have introduced a new intradermal test called Cy-TB for detecting and treating tuberculosis (TB) infection following the prioritisation of latent TB infection treatment ...
A new study conducted by researchers in Leicester and Nottingham has shown the potential for a new blood test to not only diagnose human tuberculosis (TB) but also identify those at most risk of ...